Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Avricore Health Inc

Avricore Health Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.19
  • Today's Change-0.005 / -2.56%
  • Shares traded5.50k
  • 1 Year change+11.76%
  • Beta-1.8916
Data delayed at least 15 minutes, as of Oct 04 2024 16:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.

  • Revenue in CAD (TTM)4.48m
  • Net income in CAD-2.92k
  • Incorporated2000
  • Employees--
  • Location
    Avricore Health Inc1120 - 789 West Pender StreetVANCOUVER V6C 1H2CanadaCAN
  • Phone+1 (604) 773-8943
  • Fax+1 (604) 687-2038
  • Websitehttps://avricore.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Crescita Therapeutics Inc16.84m-2.98m11.36m80.00--0.6659--0.6742-0.150-0.1500.84860.88610.68081.445.54210,525.00-12.06-0.2457-15.07-0.305954.6663.41-17.72-0.35182.32--0.0568---25.521.05-330.39---1.58--
Willow Biosciences Inc1.84m-8.70m13.70m19.00------7.45-0.0695-0.06950.0147-0.00040.249--111.5296,842.10-117.73---164.04-------472.83--0.6479--1.03--42.75--12.05------
Cytophage Technologies Ltd0.00-7.80m14.56m----2.76-----0.3779-0.37790.000.0978----------------------------0.2374-------25.88------
Kane Biotech Inc757.12k-5.48m18.46m--------24.38-0.0420.03740.0059-0.00550.15680.37513.23---113.43-77.89----60.5443.27-723.31-241.850.5679-4.731.43---94.42-20.26-17.29---19.41--
Avricore Health Inc4.48m-2.92k19.18m----8.3340.704.28-0.00006-0.000060.04430.02281.88--17.32---0.1226-85.75-0.1437-142.6536.1631.65-0.0652-116.092.76-0.65080.00--97.08196.1514.30--80.26--
Decibel Cannabis Company Inc101.04m-563.00k21.47m----0.49856.540.2125-0.0016-0.00960.23490.10530.75551.646.86---0.421-3.55-0.6781-5.1926.7015.77-0.5572-7.130.3644-3.030.5178--46.18--60.33---32.45--
Immunoprecise Antibodies Ltd24.10m-27.61m23.16m102.00--0.7049--0.9612-0.7687-0.76870.67870.88670.35466.126.16---40.63-26.70-46.68-30.3148.2156.13-114.58-85.720.8189-134.720.3289--18.6517.54-2.32--16.71--
Devonian Health Group Inc9.75m-3.17m23.72m6.00--1.78--2.43-0.0216-0.02160.06650.090.442333.072.321,625,238.00-14.37-21.02-23.15-23.9630.9529.96-32.50-131.971.06-9.410.1406--1.74-5.83-33.39------
Pharmacielo Ltd1.62m-14.15m23.76m268.00------14.67-0.0849-0.08490.0097-0.0320.06991.3824.15---61.03---165.82---86.39---873.57--0.039-2.481.37---70.96---12.27------
Data as of Oct 04 2024. Currency figures normalised to Avricore Health Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.